$47.05 1.5%
EXAS Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Exact Sciences

Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers.


Exact Sciences
Price $47.05
Target Price Sign up
Volume 1,850,000
Market Cap $8.68B
Year Range $41.33 - $75.72
Dividend Yield 0%
Revenue per Employee $771,297
Earnings Date July 31 '24
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24630M170M459M-110M-84M-0.600
Q4 '233.15B172M2.98B-50M-7.9M-0.270
Q3 '23620M169M452M790,00025M0.004
Q2 '23614M157M457M-81M-56M-0.450
Q1 '23606M157M449M-74M-48M-0.420

Insider Transactions View All

Herriott James filed to sell 9,866 shares at $60.2.
May 2 '24
COWARD D SCOTT filed to sell 44,644 shares at $60.2.
May 2 '24
Elliott Jeffrey Thomas filed to sell 11,795 shares at $60.2.
May 2 '24
Condella Sarah filed to sell 72,611 shares at $60.2.
May 2 '24
Baranick Brian filed to sell 13,279 shares at $60.2.
May 2 '24

Congress Trading View All

Politician Filing Date Type Size
Joshua Gottheimer
Democrat
Jun 8, 24 Sell $1K - $15K
Joshua Gottheimer
Democrat
Mar 7, 24 Sell $1K - $15K
Kevin Hern
Republican
Feb 11, 24 Sell $1K - $15K

What is the Market Cap of Exact Sciences?

The Market Cap of Exact Sciences is $8.68B.

How Many People Work at Exact Sciences?

As of our latest update, Exact Sciences employed approximately 6,500 people worldwide. However, it's important to note that Exact Sciences' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Exact Sciences' revenue per employee?

$771,297. To calculate Exact Sciences' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does Exact Sciences report earnings?

Exact Sciences will report its next earnings on July 31 '24.

What is the current stock price of Exact Sciences?

Currently, the price of one share of Exact Sciences stock is $47.05.

How can I analyze the EXAS stock price chart for investment decisions?

The EXAS stock price chart above provides a comprehensive visual representation of Exact Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Exact Sciences shares. Our platform offers an up-to-date EXAS stock price chart, along with technical data analysis and alternative data insights.

Does EXAS offer dividends to its shareholders?

As of our latest update, Exact Sciences (EXAS) does not offer dividends to its shareholders. Investors interested in Exact Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Exact Sciences?

Some of the similar stocks of Exact Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.